Borje Darpo

iCardiac Technologies, Inc, provides pharmaceutical cardiac safety trial services. It offers phase I QT assessment, TQT studies, phase II-IV cardiac, safety, spirometer, electronic clinical and outcome assessments. The company was founded by Alex Zapesochny, Jay B. Baker, Jean-Philippe Counderc, Alexandra Latypova, Wojciech Zareba and Mikael J. Totterman in 2006 and is headquartered in Rochester, NY.

iCardiac Technologies, Inc, provides pharmaceutical cardiac safety trial services. It offers phase I QT assessment, TQT studies, phase II-IV cardiac, safety, spirometer, electronic clinical and outcome assessments. The company was founded by Alex Zapesochny, Jay B. Baker, Jean-Philippe Counderc, Alexandra Latypova, Wojciech Zareba and Mikael J. Totterman in 2006 and is headquartered in Rochester, NY.

iCardiac Technologies, Inc, provides pharmaceutical cardiac safety trial services. It offers phase I QT assessment, TQT studies, phase II-IV cardiac, safety, spirometer, electronic clinical and outcome assessments. The company was founded by Alex Zapesochny, Jay B. Baker, Jean-Philippe Counderc, Alexandra Latypova, Wojciech Zareba and Mikael J. Totterman in 2006 and is headquartered in Rochester, NY.

iCardiac Technologies, Inc, provides pharmaceutical cardiac safety trial services. It offers phase I QT assessment, TQT studies, phase II-IV cardiac, safety, spirometer, electronic clinical and outcome assessments. The company was founded by Alex Zapesochny, Jay B. Baker, Jean-Philippe Counderc, Alexandra Latypova, Wojciech Zareba and Mikael J. Totterman in 2006 and is headquartered in Rochester, NY.

iCardiac Technologies, Inc, provides pharmaceutical cardiac safety trial services. It offers phase I QT assessment, TQT studies, phase II-IV cardiac, safety, spirometer, electronic clinical and outcome assessments. The company was founded by Alex Zapesochny, Jay B. Baker, Jean-Philippe Counderc, Alexandra Latypova, Wojciech Zareba and Mikael J. Totterman in 2006 and is headquartered in Rochester, NY.